119 related articles for article (PubMed ID: 29148820)
1. A Functional Kinase Short Interfering Ribonucleic Acid Screen Using Protease-Activated Receptor 2-Dependent Opening of Transient Receptor Potential Vanilloid-4.
Darby WG; Grace MS; Simpson KJ; Woodman OL; McIntyre P
Assay Drug Dev Technol; 2018 Jan; 16(1):15-26. PubMed ID: 29148820
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.
Zhao P; Lieu T; Barlow N; Sostegni S; Haerteis S; Korbmacher C; Liedtke W; Jimenez-Vargas NN; Vanner SJ; Bunnett NW
J Biol Chem; 2015 May; 290(22):13875-87. PubMed ID: 25878251
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.
Poole DP; Amadesi S; Veldhuis NA; Abogadie FC; Lieu T; Darby W; Liedtke W; Lew MJ; McIntyre P; Bunnett NW
J Biol Chem; 2013 Feb; 288(8):5790-802. PubMed ID: 23288842
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.
Grant AD; Cottrell GS; Amadesi S; Trevisani M; Nicoletti P; Materazzi S; Altier C; Cenac N; Zamponi GW; Bautista-Cruz F; Lopez CB; Joseph EK; Levine JD; Liedtke W; Vanner S; Vergnolle N; Geppetti P; Bunnett NW
J Physiol; 2007 Feb; 578(Pt 3):715-33. PubMed ID: 17124270
[TBL] [Abstract][Full Text] [Related]
5. Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.
Sostegni S; Diakov A; McIntyre P; Bunnett N; Korbmacher C; Haerteis S
Pflugers Arch; 2015 Apr; 467(4):687-701. PubMed ID: 24906497
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.
Grace MS; Lieu T; Darby B; Abogadie FC; Veldhuis N; Bunnett NW; McIntyre P
Br J Pharmacol; 2014 Aug; 171(16):3881-94. PubMed ID: 24779362
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.
Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW
J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282
[TBL] [Abstract][Full Text] [Related]
8. The transient receptor potential vanilloid 4 (TRPV4) ion channel mediates protease activated receptor 1 (PAR1)-induced vascular hyperpermeability.
Peng S; Grace MS; Gondin AB; Retamal JS; Dill L; Darby W; Bunnett NW; Abogadie FC; Carbone SE; Tigani T; Davis TP; Poole DP; Veldhuis NA; McIntyre P
Lab Invest; 2020 Aug; 100(8):1057-1067. PubMed ID: 32341518
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
Chen Y; Yang C; Wang ZJ
Neuroscience; 2011 Oct; 193():440-51. PubMed ID: 21763756
[TBL] [Abstract][Full Text] [Related]
10. Calcium Increase and Substance P Release Induced by the Neurotoxin Brevetoxin-1 in Sensory Neurons: Involvement of PAR2 Activation through Both Cathepsin S and Canonical Signaling.
Pierre O; Fouchard M; Buscaglia P; Le Goux N; Leschiera R; Mignen O; Fluhr JW; Misery L; Le Garrec R
Cells; 2020 Dec; 9(12):. PubMed ID: 33348659
[TBL] [Abstract][Full Text] [Related]
11. Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte.
Suzuki N; Mihara H; Nishizono H; Tominaga M; Sugiyama T
Dig Dis Sci; 2015 Dec; 60(12):3570-8. PubMed ID: 26233549
[TBL] [Abstract][Full Text] [Related]
12. PAR2-Mediated cAMP Generation Suppresses TRPV4-Dependent Ca
Rayees S; Joshi JC; Tauseef M; Anwar M; Baweja S; Rochford I; Joshi B; Hollenberg MD; Reddy SP; Mehta D
Cell Rep; 2019 Apr; 27(3):793-805.e4. PubMed ID: 30995477
[TBL] [Abstract][Full Text] [Related]
13. The nonselective cation channel TRPV4 inhibits angiotensin II receptors.
Zaccor NW; Sumner CJ; Snyder SH
J Biol Chem; 2020 Jul; 295(29):9986-9997. PubMed ID: 32493776
[TBL] [Abstract][Full Text] [Related]
14. Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance.
Bao Y; Gao Y; Hou W; Yang L; Kong X; Zheng H; Li C; Hua B
Int J Cancer; 2015 Sep; 137(6):1475-83. PubMed ID: 25708385
[TBL] [Abstract][Full Text] [Related]
15. PAR2-dependent phosphorylation of TRPV4 at the trigeminal nerve terminals contributes to tongue cancer pain.
Akasaka R; Furukawa A; Hayashi Y; Hitomi S; Koyama R; Oshima E; Tamura M; Yonemoto M; Hojo Y; Takahashi R; Shibuta I; Iwata K; Yonehara Y; Shinoda M
J Oral Biosci; 2023 Dec; 65(4):356-364. PubMed ID: 37838226
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.
Amadesi S; Nie J; Vergnolle N; Cottrell GS; Grady EF; Trevisani M; Manni C; Geppetti P; McRoberts JA; Ennes H; Davis JB; Mayer EA; Bunnett NW
J Neurosci; 2004 May; 24(18):4300-12. PubMed ID: 15128844
[TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Vanilloid 4 Activation-Induced Increase in Glycine-Activated Current in Mouse Hippocampal Pyramidal Neurons.
Qi M; Wu C; Wang Z; Zhou L; Men C; Du Y; Huang S; Chen L; Chen L
Cell Physiol Biochem; 2018; 45(3):1084-1096. PubMed ID: 29439248
[TBL] [Abstract][Full Text] [Related]
18. Mini-review: Dissecting receptor-mediated stimulation of TRPV4 in nociceptive and inflammatory pathways.
Peng S; Poole DP; Veldhuis NA
Neurosci Lett; 2022 Jan; 770():136377. PubMed ID: 34856355
[TBL] [Abstract][Full Text] [Related]
19. Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways.
Jie P; Hong Z; Tian Y; Li Y; Lin L; Zhou L; Du Y; Chen L; Chen L
Cell Death Dis; 2015 Jun; 6(6):e1775. PubMed ID: 26043075
[TBL] [Abstract][Full Text] [Related]
20. Contributions of protein kinases and β-arrestin to termination of protease-activated receptor 2 signaling.
Jung SR; Seo JB; Deng Y; Asbury CL; Hille B; Koh DS
J Gen Physiol; 2016 Mar; 147(3):255-71. PubMed ID: 26927499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
